Medicine
Skysona 30000000 injectable suspension
Skysona 30000000 injectable suspension is a prescription medicine containing Elivaldogene autotemcel for intravenous use, marketed by Genetix Biotherapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not re-freeze after thawing. Store SKYSONA frozen in the vapor phase of…
Key facts
- Active ingredient (INN)
- Elivaldogene autotemcel
- Brand
- Skysona
- Strength
- 30000000
- Dosage form
- Injectable suspension
- Route
- Intravenous
- Packs
- 1 suspension
- Marketing authorisation holder
- Genetix Biotherapeutics
- Manufacturer
- Genetix Biotherapeutics
- Origin register
- US FDA, United States
- Storage
- Do not re-freeze after thawing. Store SKYSONA frozen in the vapor phase of liquid nitrogen at less than or equal to -140°C (-220°F) until ready for thaw and administration.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07 Other nervous system medicines
- HS code (indicative)
- 3002.51Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 September 2022
- Identifiers
- RxCUI 2612552, 2612558DailyMed set ID f189502b-dc44-4289-99a6-cfba36918329NDC 73554-2111Application BLA125755
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 suspension in 1 bag | 73554-2111-1 | Genetix Biotherapeutics | 16 September 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Elivaldogene autotemcel is a prescription medicine indicated to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD), among other approved uses. MedsAcross supplies Elivaldogene autotemcel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Elivaldogene autotemcelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Skysona prescribing information (Genetix Biotherapeutics) · U.S. National Library of Medicine, DailyMed
Need Skysona 30000000 injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.